Skip to main content
Print

Pargluva FDA Approval Status

FDA Approved: No
Brand name: Pargluva
Generic name: muraglitazar
Company: Bristol-Myers Squibb and Merck & Co., Inc.
Treatment for: Diabetes, Type 2

Development timeline for Pargluva

DateArticle
Oct 27, 2005Bristol-Myers Squibb Statement on Muraglitazar, an Investigational Oral Treatment For Type 2 Diabetes
Oct 18, 2005Bristol-Myers Squibb and Merck Joint Statement on Regulatory Status of Pargluva (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes
Sep  9, 2005Bristol-Myers Squibb and Merck Joint Statement on FDA Advisory Committee Vote on Pargluva (Muraglitazar), an Investigational Oral Treatment for Type 2 Diabetes
Dec 23, 2004Bristol-Myers Squibb Provides Regulatory Update for Muraglitazar

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer